These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 20936986)
1. Systemic lupus erythematosus exhibits a dynamic and continuum spectrum of effector/regulatory T cells. Mesquita D; de Melo Cruvinel W; Araujo J; Pucci F; Salmazi K; Kallas E; Andrade L Scand J Rheumatol; 2011 Jan; 40(1):41-50. PubMed ID: 20936986 [TBL] [Abstract][Full Text] [Related]
2. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus. Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986 [TBL] [Abstract][Full Text] [Related]
3. Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus. Venigalla RK; Tretter T; Krienke S; Max R; Eckstein V; Blank N; Fiehn C; Ho AD; Lorenz HM Arthritis Rheum; 2008 Jul; 58(7):2120-30. PubMed ID: 18576316 [TBL] [Abstract][Full Text] [Related]
4. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus. Zhang B; Zhang X; Tang FL; Zhu LP; Liu Y; Lipsky PE Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598 [TBL] [Abstract][Full Text] [Related]
6. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820 [TBL] [Abstract][Full Text] [Related]
7. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Bonelli M; Savitskaya A; von Dalwigk K; Steiner CW; Aletaha D; Smolen JS; Scheinecker C Int Immunol; 2008 Jul; 20(7):861-8. PubMed ID: 18469329 [TBL] [Abstract][Full Text] [Related]
8. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients. Hahn BH; Anderson M; Le E; La Cava A Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553 [TBL] [Abstract][Full Text] [Related]
9. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients. Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042 [TBL] [Abstract][Full Text] [Related]
10. Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance. Vargas-Rojas MI; Crispín JC; Richaud-Patin Y; Alcocer-Varela J Lupus; 2008 Apr; 17(4):289-94. PubMed ID: 18413409 [TBL] [Abstract][Full Text] [Related]
11. Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis. Xing Q; Su H; Cui J; Wang B Immunol Invest; 2012; 41(1):15-27. PubMed ID: 21563925 [TBL] [Abstract][Full Text] [Related]
12. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus. Kuhn A; Beissert S; Krammer PH Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367 [TBL] [Abstract][Full Text] [Related]
13. Frequency and functional activity of Th17, Tc17 and other T-cell subsets in Systemic Lupus Erythematosus. Henriques A; Inês L; Couto M; Pedreiro S; Santos C; Magalhães M; Santos P; Velada I; Almeida A; Carvalheiro T; Laranjeira P; Morgado JM; Pais ML; da Silva JA; Paiva A Cell Immunol; 2010; 264(1):97-103. PubMed ID: 20553755 [TBL] [Abstract][Full Text] [Related]
14. Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus. Barath S; Aleksza M; Tarr T; Sipka S; Szegedi G; Kiss E Lupus; 2007; 16(7):489-96. PubMed ID: 17670847 [TBL] [Abstract][Full Text] [Related]
15. Identification of regulatory T cells in systemic lupus erythematosus. Gerli R; Nocentini G; Alunno A; Bocci EB; Bianchini R; Bistoni O; Riccardi C Autoimmun Rev; 2009 Mar; 8(5):426-30. PubMed ID: 19185065 [TBL] [Abstract][Full Text] [Related]
16. CD26: a negative selection marker for human Treg cells. Salgado FJ; Pérez-Díaz A; Villanueva NM; Lamas O; Arias P; Nogueira M Cytometry A; 2012 Oct; 81(10):843-55. PubMed ID: 22949266 [TBL] [Abstract][Full Text] [Related]
17. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro. Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692 [TBL] [Abstract][Full Text] [Related]
18. Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus. Alexander T; Sattler A; Templin L; Kohler S; Groß C; Meisel A; Sawitzki B; Burmester GR; Arnold R; Radbruch A; Thiel A; Hiepe F Ann Rheum Dis; 2013 Sep; 72(9):1549-58. PubMed ID: 23264341 [TBL] [Abstract][Full Text] [Related]
19. CD4(+)CD25(+)CD127(-) and CD4(+)CD25(+)Foxp3(+) Regulatory T Cell Subsets in Mediating Autoimmune Reactivity in Systemic Lupus Erythematosus Patients. Żabińska M; Krajewska M; Kościelska-Kasprzak K; Jakuszko K; Bartoszek D; Myszka M; Klinger M Arch Immunol Ther Exp (Warsz); 2016 Oct; 64(5):399-407. PubMed ID: 27156107 [TBL] [Abstract][Full Text] [Related]